Clinical Trial Update: Evaluating the Pharmacokinetics and Pharmacodynamics of Romiplostim in Patients With Immune Thrombocytopenia (ITP) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update evaluates the pharmacokinetics and pharmacodynamics of romiplostim in patients with immune thrombocytopenia (ITP) in Phase 1/2. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Romiplostim (romiplostim)

Snippet

Sponsor: Kyowa Kirin China Pharmaceutical Co., Ltd. | Conditions: Immune Thrombocytopenia (ITP) | Phase 1, Phase 2 | Status: COMPLETED